FEMS Yeast Res 2004, 4:401–408 PubMedCrossRef 27 Schaller M,

FEMS Yeast Res 2004, 4:401–408.PubMedCrossRef 27. Schaller M, Lorlatinib purchase Borelli C, Korting HC, Hube B: Hydrolytic enzymes as virulence factors of Candida albicans . Mycoses 2005, 48:365–377.PubMedCrossRef 28. De Bernardis F, Mondello F, San Millán R, Pontón J, Cassone A: Biotyping and virulence properties of skin isolates of Candida parapsilosis .

J Clin Microbiol 1999, 37:3481–3486.selleck kinase inhibitor PubMed 29. Pichová I, Pavlicková L, Dostál J, Dolejsí E, Hrusková-Heidingsfeldová O, Weber J, Ruml T, Soucek M: Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae . Eur J Biochem 2001, 268:2669–2677.PubMedCrossRef 30. Khun D, Chandra J, Mukherjee PK, Ghannoum MA: Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002, 70:878–888.CrossRef 31. Ozkan S, Kaynak F, Kalkanci A, Abbasoglu U, Kustimur S: Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents. Mem Inst Oswaldo Cruz 2005, 100:319–324.PubMedCrossRef 32. Dagdeviren M, Cerikcioglu N, Karavus M: Acid proteinase, phospholipase, and adherence

properties of Candida parapsilosis strains isolated fron clinical specimens of hospitalized patients. Mycoses 2005, 48:321–326.PubMedCrossRef 33. Lin DM, Wu LC, Rinaldi MG, Lehmann PF: Three distinct selleck chemicals llc genotypes within Candida parapsilosis from clinical sources. J Clin Microbiol 1995, 33:1815–1821.PubMed 34. Levitz SM: Interactions of Toll-like receptors with fungi. Microb Infect 2004, 6:1351–1355.CrossRef 35. Romani L: Immunity to fungal infections. Nat Rev Immunol 2004, 4:11–24.CrossRef 36. Zelante T, Montagnoli C, Bozza S, Gaziano R, Bellocchio S, Bonifazi P, Moretti S, Fallarino F, Puccetti P, Romani L: Receptors

and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi. Adv Exp Med Biol 2007, 590:209–221.PubMedCrossRef 37. Kocsubé S, Tóth M, Vágvölgyi C, Dóczi I, Pesti M, Pócsi I, Szabó J, Varga J: Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. J Med Microbiol 2007,56(Pt 2):190–5.PubMedCrossRef 38. Hensgens LA, Tavanti A, Mogavero ADAMTS5 S, Ghelardi E, Senesi S: AFLP genotyping of Candida metapsilosis clinical isolates: Evidence for recombination. Fungal Genet Biol 2009,46(10):750–758.PubMedCrossRef 39. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM: Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals. PLoS Pathog 2010,6(1):e1000713.PubMedCrossRef 40. Sabino R, Sampaio P, Rosado L, Stevens DA, Clemons KV, Pais C: New polymorphic microsatellite markers able to distinguish among. Candida parapsilosis senso stricto isolates. J Clin Microbiol 2010, 48:1677–1682.

Comments are closed.